Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib is effective and safe for treating severe alopecia areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.